乌鸦传媒

Crystal Phend

Crystal Phend

Authors >

Crystal Phend

Crystal Phend is a contributing editor with 乌鸦传媒, where she's been covering medical news of all stripes since 2006.

Connect:

email image

Latest from Crystal Phend

HFSA over a photo of Huntington Convention Center in Cleveland, Ohio.

<乌鸦传媒>Weight-Loss Drug Benefit Spans HFpEF, HFmrEF

STEP-HFpEF trial results come out consistent across ejection fraction

Illustration of different comorbidities over a heart in failure

<乌鸦传媒>Managing Heart Failure Comorbidities

Hypertension, atrial fibrillation, type 2 diabetes, and anemia care may require adjustment in HF

Illustration of different comorbidities over a heart in failure

<乌鸦传媒>For Your Patients: Managing Heart Failure With Other Chronic Conditions

Having a combination of HF and other medical issues can impact how you approach each of them

A close up photo of a bag of parenteral nutrition

<乌鸦传媒>No Benefit to Tight Glucose Control in ICU

Trial attempts to settle the controversy once and for all

A photo of a box of Sudafed PE.

<乌鸦传媒>FDA Panel Favors Dropping OTC Decongestant

Unanimous vote that the drug is ineffective

A photo of a box of Sudafed PE

<乌鸦传媒>FDA Reviewers Say OTC Decongestant Doesn't Work

But they acknowledge that taking the only shelf-accessible product off the market raises issues

A photo of a woman in a wheelchair opening the driver鈥檚 door of her car.

<乌鸦传媒>Vaccines Not Linked to MS Flare-Ups

Nationwide French study might clear up a decade of doubts

ESC over a photo of Amsterdam RAI Convention Centre.

<乌鸦传媒>No Aspirin After PCI? Extended P2Y12 Monotherapy? Trials Weigh In

Two trials read out, but generalizability is the question

ESC over a photo of Amsterdam RAI Convention Centre.

<乌鸦传媒>Novel Amyloid Drug Improves Mid-Term Outcomes in ATTR Cardiomyopathy

Pivotal trial "suggests the tantalizing possibility of genuine clinical improvement"

ESC over a photo of Amsterdam RAI Convention Centre.

<乌鸦传媒>Less Atrial Pacing Doesn't Cut Afib in Sinus Node Dysfunction

Trial debunks strategy for higher-risk group

鈥�

16

鈥�